Your Web News in One Place

Help Webnuz

Referal links:

Sign up for GreenGeeks web hosting
March 6, 2019 04:09 am GMT

FDA approves esketamine nasal spray, the first new major depression drug in more than 30 years

In one of the most significant milestones for depression treatment in decades, the U.S. Food and Drug Administration announced today that it has approved a new drug with esketamine, a derivative of ketamine. Made by Johnson & Johnson under the brand name Spravato, the drug is meant to be taken as a nasal spray in […]

Original Link: http://feedproxy.google.com/~r/Techcrunch/~3/7anITeNysQc/

Share this article:    Share on Facebook
View Full Article

Techcrunch

TechCrunch is a leading technology blog, dedicated to obsessively profiling startups, reviewing new Internet products, and breaking tech news.

More About this Source Visit Techcrunch